论文部分内容阅读
目的探讨不同药物联合应用米非司酮在终止瘢痕子宫中期妊娠中的临床疗效。方法本研究以我院2009年1月至2011年1月之间所收治的81例瘢痕子宫中期妊娠患者为观察对象,利用随机分组法将其分为实验组和对照组,对照组患者使用利凡诺联合米非司酮治疗,实验组患者在上述治疗基础上使用米索前列醇进行治疗,对比两组患者的临床治疗效果。结果实验组患者Bisihop评分结果与治疗总有效率均显著优于对照组患者,两组患者的实验数据对比具有显著的统计学差异(P<0.05)。结论本次实验结果表明,不同药物联合应用米非司酮用于终止瘢痕子宫中期妊娠,具有较为理想的流产成功率,缓解产妇痛苦,因而临床应用价值较高。
Objective To investigate the clinical efficacy of different drugs combined with mifepristone in the termination of uterine scar pregnancy. Methods In this study, 81 cases of uterus with uterus during pregnancy in our hospital from January 2009 to January 2011 were selected as the observation object, divided into experimental group and control group by random grouping method, Fannuo combined with mifepristone treatment, the experimental group patients on the basis of the above treatment with misoprostol for treatment, compared the clinical efficacy of two groups of patients. Results Bisihop score and total effective rate in the experimental group were significantly better than those in the control group. There was significant statistical difference between the two groups in the experimental data (P <0.05). Conclusion The results of this experiment show that the combination of different drugs with mifepristone for termination of uterine scar pregnancy has the ideal rate of success of abortion and relieve the pain of maternal, which has high clinical value.